Treasure Global Inc. Reports Third Quarter Year 2025 Financial Results
Notified -
Globe Newswire16-05-2025, 03:28
Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis 7-06-2024, 15:30